FindTrial
Sign In

Protective effect of high-density lipoprotein in infective endocarditis patients after valve surgery:A cohort study

Protective effect of high-density lipoprotein in infective endocarditis patients after valve surgery:A cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400086252
Enrollment
Unknown
Registered
2024-06-27
Start date
2024-07-01
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infective endocarditis

Interventions

Group one (higher-high-density lipoprotein):None
Group two (lower-high-density lipoprotein):None

Sponsors

Beijing Anzhen Hospital, Capital Medical University, Beijing, China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) over 18 years of age; (2) diagnosed with IE based on Duke diagnostic criteria[3]and underwent valve surgery.

Exclusion criteria

Exclusion criteria: (1) without data for lipoproteins; (2) lost to follow-up

Design outcomes

Primary

MeasureTime frame
High-density lipoprotein;—

Secondary

MeasureTime frame
low-density lipoprotein;total cholesterol;triglyceride;fasting plasma glucose;—

Countries

China

Contacts

Public ContactGong Ming

Beijing Anzhen Hospital, Capital Medical University, Beijing, China

gongming@mail.ccmu.edu.cn+86 139 0121 2470

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026